UK academia, clinical science, and the NHS: where we’ve been, and where we’re going

By Cas Gudgeon

This issue marks the 75th anniversary of Palatinate, a milestone that arrives in the wake of waves of nationwide UCU strikes, mounting NHS pressures, and a slow-burning exodus of researchers, clinical scientists, doctors, and nurses. A little over three years after the start of the Covid-19 pandemic, and in the midst of a cost-of-living crisis, where do we stand now?

Industry clinical trials collapsed during the pandemic

Last October, the Association of the British Pharmaceutical Industry (ABPI) released an annual report which revealed the decline of industry clinical trials in the UK. Between 2017 and 2021, the number of clinical trials in the country decreased by 41%. This was accompanied by a 44% drop in the number of patients with access to clinical trials on the National Institute for Health and Care Research Clinical Research Network (NIHR CRN), with roughly 22,000 fewer patients accessing novel therapies undergoing advanced trials.

The report also found that the UK has fallen behind other countries in the life sciences sector, in part due to issues stemming from pay and pension cuts. In 2017, the UK ranked 3rd globally in the number of phase I trials in progress, 2nd in phase II trials, and 4th in phase III trials. In 2021, the UK was in 4th place in phase I trials, 6th in phase II trials, and 10th in phase III trials, having been overtaken by countries such as Spain, Australia, and Japan.

“The time it takes to set up trials and recruit patients in the UK is out of line with our global competitors and is moving in the wrong direction,” said Richard Torbett, Chief Executive of the Association of the British Pharmaceutical Industry (ABPI). “As a result of this, and growing commercial pressures, pharmaceutical companies are increasingly looking elsewhere when choosing where to develop and launch new medicines and vaccines.”

It is estimated that the UK life sciences sector – if maintained and invested in adequately in line with recommendations by pharmaceutical companies such as AstraZeneca, Pfizer, and Roche – could potentially yield significant economic benefits. Over the next 30 years, R&D investment could net the UK economy an additional £68 billion, as well as a 40% decrease in disease burden.

Baroness Brown, Chair of the Science and Technology Committee, stated “Against the backdrop of intense pressure on the NHS, clinical research is on a precipice. Clinical research is not a ‘nice-to-have’ but vital for the healthcare service to become more efficient and effective. Rather than an additional pressure, the ability to engage with research can aid recruitment and retention for staff, and can bring in industry funding.

“Without urgent actions from the Government, such as those recommended in our letter, the UK’s clinical research capacity could be permanently diminished, leaving the NHS, patients and the UK economy worse off in the future.”

Growing discontent in academia portends mass exodus

At the end of last year, over 70,000 staff members and academics across 150 universities took part in the largest highest education strike in the history of the UK.

In correspondence with Nature, researchers stated that deterioriating working conditions were jeopardising the future of scientific research. Richard Harris, a geographer at the University of Bristol, wrote “This is the 12th year in a row in which the employers have offered below-inflation pay increases, which means the salary scales are getting less and less each year. They’ve offered a 3% pay increase, but inflation is about 11%. That’s an 8% pay cut in real terms, equivalent to losing one month’s pay.”

“I’m going to stop peer reviewing for profit-making publishers until the industrial dispute is settled, because it relies on goodwill and very little of it’s actually paid […] When you keep cutting people’s pay and pensions, that goodwill begins to dissipate.”

One of the strikers’ conditions was the reversal of a cut to pensions, which amounted to a 35% decrease in retirement income. The cut was pushed through following an evaluation of a report in March 2020 which found that the Universities Superannuations Scheme (USS) had a deficit exceeding £14 billion. However, the deficit has since been resolved according to the UCU, following the release of the USS financial monitoring report which highlighted a surplus of £1.8 billion.

The UCU has also reported that two thirds of academic staff intend to leave higher education at some point within the next five years, with three quarters of researchers saying that they were likely or very likely to leave academia. In a survey of almost 7,000 researchers across 100 institutions in Britain, 90% of UCU staff said they were not optimistic about the future of academia, and 60% of staff were unhappy about the prospect of working in higher education for the duration of their remaining career.

Across the country, the pandemic and the cost-of-living crisis together have inflamed workers’ discontent, culminating in waves upon waves of strikes in the public sector. Helen Coulshed, a chemist at King’s College London, wrote “While some vice-chancellors earn £500,000 and can claim expenses for all sorts of luxuries, our PhD students and staff are using food banks. They’re deciding which days they can eat, or which meals to skip. That level of discrepancy in one university is not acceptable.

“At King’s, student numbers have increased by 25% over the past two years. At the same time, we’ve had a 3.9% increase in staff. So, our staff-to-student ratio has gone bonkers, which has knock-on effects in terms of availability of our time and head space to think about research.”

Tidal wave of NHS resignations

Tens of thousands of skilled and experienced nursing staff, many aged 21 to 50, are leaving the profession, according to an RCN report released on February 13. The report lays out the root causes of poor retention and growing resignation. Between 2018 and 2022, just under 43,000 nurses left the Nursing and Midwifery Council (NMC) register. In 2020/21 the number of nurses leaving the NMC grew by 9%, followed by a further 3% in 2022.

Recent figures from UCAS indicate that, in addition to record numbers of experienced nurses leaving the NHS, fewer nurses were joining the profession. Oft-cited reasons for leaving included inadequate pay, unsafe working conditions, harassment and discrimination at work, and insufficient staffing to ensure patient safety. Since 2010, some nursing roles within the RCN have seen real-terms wage cuts of up to 20% over the course of the last two decades; the average NHS nurse has had a pay cut of 8% in real-terms. Similarly, NHS hospital doctors have had their real-terms pay cut by 7%.

Figures from the NHS staffing trackers show that 140,000 hospital and community health staff left the NHS service in the year to September 2021, including one in 10 nurses and one in 18 consultants. For nurses, the most common reasons cited for leaving included excessive pressure, personal circumstances, and retirement. Notably, just 14% of nurses who left after the beginning of the pandemic said that the the pandemic had influenced their decision to leave. For GPs, burnout, job dissatisfaction and physical working conditions were what led many to leave the profession, with many GPs reporting that the amount of time spent on ‘unimportant’ tasks was a contributing factor.

One of the government’s targets in 2023/24 was to have 50,000 more nurses working in the NHS. However, internal NHS estimates uncovered by The Independent indicated that this target was unlikely to be met. In December and January, a record-breaking 50,000 patients a week waited for over 12 hours to be admitted in A&E.

“Nursing staff are leaving the profession, realising they can get similar or better pay in supermarkets and retail without the stress of the job,” said Pat Cullen, general secretary and chief executive of the Royal College of Nursing. “Poor pay is creating severe staff shortages and making patients unsafe. Nurses, patients and the public deserve better than a government that won’t listen.”

Image: Magnus Hagdorn, Flickr